Free Newsletter
Scientists map genetic mutations in cancer
British scientists have mapped about 200 genetic mutations involved in breast and colon cancer, work that is likely to speed new diagnostics as well as new therapies customized for each individual patient. The researchers concluded that each tumor appears to be unique, giving credence to their conclusion that these cancers are far more complex than previously thought. And the work identified cancer genes that previously had not been identified. The report, which appears in Science, gives drug developers more targets for developing therapies that can be targeted at individual patients.
- read this BBC report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


